Archives: Speakers

Since joining GlobalData, Magda has been creating FMCG content on a cross-sector basis including case studies and syndicated projects on product innovations and emerging market trends. Being a part of the Consumer Division, she specializes in packaging, foodservice and consumer goods industries. Magda holds an BSc Honours in Economics and MSc in Economic Policy and Analysis.

Mirko Markovic is the Growth Countries Sales Manager and International Key Account Manager at E.ON Energy Infrastructure Solutions GmbH (EIS). He plays a leading role in E.ON EIS by helping businesses around the world transition to sustainable energy. With extensive experience in international energy sales, EIS and Mirko helps large companies navigate the challenges of lowering carbon emissions, ensuring energy security and meeting new regulations.

He is particularly skilled at balancing technical infrastructure needs with financial goals in the projects. Mirko provides custom plans that cover every stage of a project. At EIS, his work focuses on, from the initial design and financing to long term operations. Together we’re delivering “Energy as a Service” models that help businesses cut costs while significantly reducing their environmental impact. By building strong international partnerships, Mirko helps organizations turn sustainability into a real competitive advantage. He is dedicated to creating future proof energy solutions that work for both the planet and our business.

As a Business Development Leader, Michael drives Decom Engineering’s global commercial strategy and regional growth across the globe. He leads high-value tendering and multimillion-pound wins, managing a global team to deliver scalable market expansion and board-level strategic insight”

Experience
Accomplished, trilingual MD, PhD clinical oncologist with 18+ years of PHARMA / CRO in different countries.
Deep knowledge in Medical Affairs and Clinical Research and development, specifically clinical trials Phase I
included first in human through Phase IV
> Skilled professional in complex aspect of oncology and molecular genetics, gastrointestinal (gastric cancer, CRC
and HCC), genitourinary cancer, skin cancer and Immunotherapy including CAR-T cell, CAR NK-cell and others)
> Prior to joining PAREXEL, roles included serving as a Senior Oncology / Hematology medical manager in Ely Lilly,
GlaxoSmithKline, ROCHE and as a Latin America Medical Scientific Liaison ASCI (Antigen Specific Cancer
Immunotherapies) for GlaxoSmithKline
> Immediate roles prior to Parexel included 2 years as Oncology / Hematology Associate Medical Director at IQVIA

Expertise
> Expertise in a variety of solid tumors indications (gastrointestinal, genitourinary and skin cancer) and immuno-
oncology and Cell & Gene therapy
> Provide scientific and strategic guidance, training and advice
> Published author in several clinical literature citations in PubMed and other short contributions in oncology books
including update and reviews

Education
> Educate and training as a Clinical Oncologist in Universidad Central de Venezuela (UCV)
PhD in molecular oncology in Instituto Venezolano de Investigaciones Cientificas (IVIC)

Aglinda Hoxha is a senior leader in wealth management, presently a Desk Head HNW at UBS Wealth Management UK. With over two decades of experience across client advisory, front‑office leadership, and risk governance, she is recognised for driving commercial growth while championing a disciplined, client‑centric control environment. Previously serving as Head of Front Office Business Risk Management, Aglinda played a pivotal role in shaping the risk and regulatory framework underpinning the UK franchise, partnering with leadership teams to turn complex requirements into practical enablers of performance. Her foundation in frontline client management—built at Barclays Wealth—continues to guide her coaching‑focused leadership style, which has supported the development of high‑performing professionals across the business. Aglinda holds an Executive MBA from the University of Cambridge and brings a strong perspective on digital innovation, scalable growth, and sustainable client value creation to her role.

My experience includes challenging and diverse roles within asset management investment banking financial services regulation and the audit of financial services.

I am qualified as: a Chartered MSCI a Fellow Chartered Global Management Accountant Barrister of England and Wales. My first degree was a Masters in Computer Systems Engineering which was dual honours in electronic engineering and computer science. My dissertation was in the computational analysis of multicompartmental pharmacokinetic mathematical models. In addition, I have also renewed my machine learning skills by means of Andrew Ng’s Deep Learning course. I have also given speeches on behalf of the FCA on prudential regulation and represented the UKs interests at IOSCO and various ESAs.